Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Healthcare Global Enterprises Limited (NSE: HCG), ISIN INE075I01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HCG last traded at ₹712.55 (-0.06%), with a 52-week range of ₹513.40 to ₹799.47 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 64.21%, FIIs 2.74%, DIIs 19.20%, mutual funds 15.43%.
EquiSense Score (ECS): 76/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.